Similar articles for PMID: 28730692

Year	Number of Results
1948	1
1949	1
1958	1
1966	1
1967	1
2002	1
2007	1
2008	1
2010	1
2011	2
2012	4
2013	15
2014	19
2015	19
2016	29
2017	34
2018	33
2019	29
2020	26
2021	19
2022	17
2023	8
2024	1

1

Self-perception of voice in transgender persons during cross-sex hormone therapy.

Bultynck C, Pas C, Defreyne J, Cosyns M, den Heijer M, T'Sjoen G. Bultynck C, et al. Laryngoscope. 2017 Dec;127(12):2796-2804. doi: 10.1002/lary.26716. Epub 2017 Jul 21. Laryngoscope. 2017. PMID: 28730692

2

Associations between the Transsexual Voice Questionnaire (TVQ^MtF ) and self-report of voice femininity and acoustic voice measures.

Dacakis G, Oates J, Douglas J. Dacakis G, et al. Int J Lang Commun Disord. 2017 Nov;52(6):831-838. doi: 10.1111/1460-6984.12319. Epub 2017 Apr 19. Int J Lang Commun Disord. 2017. PMID: 28425220

3

Organizing the voice questionnaire for transgender persons.

Bultynck C, Pas C, Defreyne J, Cosyns M, T'Sjoen G. Bultynck C, et al. Int J Transgend Health. 2019 May 8;21(1):89-97. doi: 10.1080/15532739.2019.1605555. eCollection 2020. Int J Transgend Health. 2019. PMID: 33005904 Free PMC article.

4

Transsexual Voice Questionnaire for Male-to-female Brazilian Transsexual People.

Schwarz K, Fontanari AMV, Mueller A, Costa AB, Soll B, da Silva DC, Cielo CA, Kuhl G, Spritzer PM, Schneider MA, Dorfmann ME, Lobato MIR. Schwarz K, et al. J Voice. 2017 Jan;31(1):120.e15-120.e20. doi: 10.1016/j.jvoice.2016.02.012. Epub 2016 Apr 14. J Voice. 2017. PMID: 27146028

5

Further Evidence of the Construct Validity of the Transsexual Voice Questionnaire (TVQ^MtF) Using Principal Components Analysis.

Dacakis G, Oates JM, Douglas JM. Dacakis G, et al. J Voice. 2017 Mar;31(2):142-148. doi: 10.1016/j.jvoice.2016.07.001. Epub 2016 Aug 8. J Voice. 2017. PMID: 27515560

6

Gonadal suppressive and cross-sex hormone therapy for gender dysphoria in adolescents and adults.

Smith KP, Madison CM, Milne NM. Smith KP, et al. Pharmacotherapy. 2014 Dec;34(12):1282-97. doi: 10.1002/phar.1487. Epub 2014 Sep 15. Pharmacotherapy. 2014. PMID: 25220381 Review.

7

Voice and Stroboscopic Characteristics in Transgender Patients Seeking Gender-Affirming Voice Care.

Young VN, Yousef A, Zhao NW, Schneider SL. Young VN, et al. Laryngoscope. 2021 May;131(5):1071-1077. doi: 10.1002/lary.28932. Epub 2020 Aug 4. Laryngoscope. 2021. PMID: 32750170

8

Efficacy of hormonal and mental treatments with MMPI in FtM individuals: cross-sectional and longitudinal studies.

Oda H, Kinoshita T. Oda H, et al. BMC Psychiatry. 2017 Jul 17;17(1):256. doi: 10.1186/s12888-017-1423-y. BMC Psychiatry. 2017. PMID: 28716082 Free PMC article.

9

Cardiovascular Disease Among Transgender Adults Receiving Hormone Therapy: A Narrative Review.

Streed CG Jr, Harfouch O, Marvel F, Blumenthal RS, Martin SS, Mukherjee M. Streed CG Jr, et al. Ann Intern Med. 2017 Aug 15;167(4):256-267. doi: 10.7326/M17-0577. Epub 2017 Jul 25. Ann Intern Med. 2017. PMID: 28738421 Review.

10

Effect of pubertal suppression and cross-sex hormone therapy on bone turnover markers and bone mineral apparent density (BMAD) in transgender adolescents.

Vlot MC, Klink DT, den Heijer M, Blankenstein MA, Rotteveel J, Heijboer AC. Vlot MC, et al. Bone. 2017 Feb;95:11-19. doi: 10.1016/j.bone.2016.11.008. Epub 2016 Nov 11. Bone. 2017. PMID: 27845262 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

197 results

Results by year